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Abstract 
Purpose: To study the prevalence of diabetic retinopathy in known diabetic patients attending the 
diabetes outpatient department (OPD) of Sind Government Hospital (SGH), New Karachi Township 
(NKT), Pakistan. 
Methods: A cross-sectional observational study was carried out at the diabetic OPD of SGH, NKT over 
the period of 17 months from March 2013 to August 2014. The selected patients were interviewed 
based on a questionnaire; laboratory investigations were performed and examination of the eye was 
conducted by a specialist ophthalmologist. One hundred and fifty four (154) subjects out of 305 patients 
contacted fully completed the study. Stratification of the data on gender basis was done, after which 
one-way ANOVA, χ2 test of correlation, binary logistic regression and relative risk analyses were carried 
out using SPSS-20. 
Results: It was found that 66 % men of normal weight (χ2 = 4.667, p < 0.05) and 60.7 % overweight 
women (χ2 = 5.143, p < 0.05) were more likely to present with diabetic retinopathy (DR). Prevalence of 
DR in this target population was 42.86 % (N = 66). Background DR (56 %) and maculopathy (23 %) 
were more prevalent than advanced conditions of the disease. There was no gender-based 
preponderance for the presentation of DR (χ2 = 0.663; p > 0.05), nor was this seen in different ethnic 
groups. 
Conclusion: DR is prevalent in the target population and, therefore, emphasis should be on the 
education of the local population of New Karachi Township on how to attain euglycemic state with 
regular medication, diet and exercise to avoid development and progress of DR. 
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Type II Diabetes Mellitus (DM II) is a chronic 
progressive condition which is marked by 
hyperglycemia usually due either to hypo-
insulinemia or insulin resistance [1]. Currently 
285 million people are affected with DM II 
worldwide and this number is expected to reach 
439 million by the year 2030 [2]. Pakistan is 
amongst the highly affected countries and is 
ranked 7th in global prevalence of DM II [3]. 
About 10 % of the adult population in Pakistan 
suffers from this disorder [4]. 
 
Long standing DM is associated with macro- and 
micro-vasculature abnormalities [5], pathological 
changes of neurons, skin, blood vessels and lens 
[6,7] leading to hypertension, end stage renal 
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failure, blindness and neuropathies [6]. The 
degree of hyperglycemia and duration of 
diabetes are often linked with the development of 
these complications. 
 
Diabetes remains leading cause of visual 
impairment in Western and Asian countries [8] in 
population under 60 years of age [9]. Patients 
with DR are 25 times more likely to become blind 
than non-diabetics [10]. The rate of DR in DM is 
4 % whereas in DM II it is 1.6 % [11]. Prevention 
and progression of the complication can be 
minimized by timely diagnosis and strict glycemic 
and blood pressure control [9]. 
 
The present study was conducted to study the 
prevalence of diabetic retinopathy in known 
diabetic patients attending the diabetes 
outpatient department of Sind Government 






This cross-sectional observational study was 
carried out on 305 patients who visited diabetes 
OPD of Sind Government Hospital, New Karachi 
Township for the period of 17 months from March 
2013 to August 2014 out of which 154 patients 




Sind Government hospital is the major public 
sector tertiary hospital in New Karachi Township 
which caters all the patients from Surjani town to 
North Karachi and New Karachi. People also 
attend the facility from Buffer zone and all the 
sub-urban areas around New Karachi Township. 
Total patient turnover in the general OPD is 
about 75000 patients/month, inclusive of new 
and follow-up cases. Diabetes OPD on the 
average takes care of 1200 patients/month. The 
hospital provides out-patient and in-patient 
services to people from the low-income group. 
Medicines available in the pharmacy of the 
hospital is provided by charity and Islamic zakat, 




The patients represented the general population 
of New Karachi Township including Buffer zone 
and sub-urban area around New Karachi. All the 
patients who were diagnosed DM > 5 years and 





For the collection of data, an interviewer 
administered questionnaire in an initial pilot study 
performed on 20 patients from the same study 
population, after which face validity of the 
questionnaire was constructed by performing 
principle component analysis and Cronbach’s 
alpha test. 
 
Patients taken for the study were known 
diabetics with at least 5 years duration. Detailed 
history regarding socio-demographic information, 
general health and questions regarding onset, 
duration, treatment and nature of control of 
Diabetes and Ocular complications were asked. 
An informed consent was obtained from the 
patients after seeking proper permission from 
higher authorities. Blood glucose along with 
Glycated hemoglobin (HbA1c) and lipid profiles 
were procured [10].  The study protocol was 
approved by the ethical committee of Sind 
Government Hospital (approval ref # 
SGHNK/922). 
 
Sample size was calculated as in Eq 1 [12] for 
proportion or descriptive study. 
 
n = [DEFF*Np(1-p)]/[(d2/Z21-α/2*(N-1)+p*(1-p)] …. (1) 
 
At the population size of 0.1 million and 
anticipated percent frequency 10 % for DM II in 
Pakistan [4], the sample size at 95 % confidence 




After adequate dilatation with 1 % tropicamide, 
detailed fundal examination was carried out by 
indirect ophthalmoscopy and retinoscopy. The 
diagnostic criteria are summarized in Table 1. 
Retinopathy was classified into the following 
categories, according to the International Clinical 
DR Disease Severity Scale; normal, Background 
DR, pre-proliferative DR and proliferative DR, 
whilst presence/absence of macular edema 




Data were expressed mean ± SEM for 
continuous variables and number of subjects and 
percentages for categorical variables. Patients 
were stratified by gender and type of primary 
treatment administered i.e. either insulin or oral 
hypoglycemic agents. Continuous variables were 
compared with one way ANOVA and Pearson’s 
Chi square test was applied on categorical 
variables.  
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Retinal edema/thickening at 
macular region 





IRMA (Intra retinal micro vascular 
abnormalities) 
Large blot hemorrhages 
Neo-vascularization at disc 
Neo-vascularization else where 
Vitreous hemorrhage 
Pre-retinal fibrosis 
Tractional retinal detachment 
Rubiosis 
 
Binary logistic regression analysis was 
performed on whole data set as well as after 
stratification on gender basis to ascertain the 
effects of covariates like age, gender, and insulin 
use, duration of diabetes, BMI, HbA1c, fasting 
and random glucose and serum cholesterol 
levels for likelihood on participants that they will 
develop diabetic retinopathy. The results of this 
analysis were expressed in odd ratios with their 
95% CI. Relative risk of retinopathy with or 
without administration of insulin was also 
performed.  
 
All p-values were two sided and p < 0.05 was 
considered statistically significant. Statistical 
analysis was performed using SPSS-20 software 






The Kaiser-Meyer-Olkin measure of sampling 
adequacy for the 36 items were examined was 
0.67, and Bartlett’s test of sphericity was highly 
significant (χ2 (496) = 4236.87, p < .0001).  
Initially communalities of four items were found to 
be less than 0.3 so those items were removed 
and the test was run again. After which the 
communalities were all above 0.3, further 
confirming that each item shared some common 
variance with other items.  Given these overall 
indicators, therefore, factor analysis was 




The questionnaire was divided into two major  
components, first portion collect information on 
history and laboratory investigations and second 
portion on opthalmoscopic examination. First 
portion consisted of 34 items (α = 0.68) with 
inter-item correlation of 0.061. The second 
portion consisted of 15 items (α = 0.86) with 




Based on the sample size calculation, was 
known diabetic patients attending diabetic OPD 
at Sind Government hospital were approached. 
Out of 308 patients contacted 154 completed the 
study (50 % response rate) after excluding 73 
patients who had DM II < 5 years and 81 patients 
who were lost to follow. Mean age of patients in 
the study was 50.59 ± 10.24 years out of which 
27.3 % (N = 42) were males and 72.7 % (N = 
112) were females. Mean age of men was 56.2 ± 
9.3 and of females was 48.47 ± 9.8. One way 
ANOVA showed significant difference between 
groups, F = 19.71 (152, 1), p < 0.001. 74 % (N = 
111) of the respondents were married and 25 % 
were widowed. 2 % (N = 3) were single. The 
mean height weight and BMI was 156.55 ± 8.47 
cm, 64.33 ± 13.61 kg and 26.28 ± 5.3 kg/m2 
respectively. The prevalence of obesity (BMI ≥ 
25 kg/m2) in the target population was 53.2 and 
33 % obesity was observed in males and 69.7 % 
obesity was observed in females (χ2 = 9.19, df = 
1, p = 0.002).The prevalence of hypertension 




Majority of the participants (68 %) had either 
primary or no formal education and only 7 % of 




Gender analysis showed that 66% of men had 
normal weight, 29.67 % of whom were suffering 
from retinopathy. In contrast, 60.7 % females 
were overweight, and 28 % of these females had 
retinopathy. Gender-based sample characteris-
tics and prevalence of retinopathy are provided in 
Table 2. 
 
Prevalence, clinical and biochemical co-
relates of diabetic retinopathy 
 
The prevalence of DR in the study population 
was 42.86 % (N = 66) out of which 85 % (N = 56) 
presented with bilateral DR and 15 % (n = 10) 
presented with unilateral DR. There was non- 
significant gender difference in prevalence of DR 
(male – 42 %; female – 49 %; p = 0.42). 
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Prevalence of cataract was 34.4 % (N = 53) in 
both eyes and 4.55 % (N = 7) in single eye (male 
- 30.9 %; female - 30.5 %; p = 0.41). In patients 
with DR, 56 % (N = 37) of the patients had 
background retinopathy, 5 % (N = 3) had pre-
proliferative DR, 6 % (N = 4) had proliferative 
DR, and 25 % (N = 18) of patients had 
maculopathy. 
 
Prevalence of DR was 53.8 % (N = 7 out of 13) 
in Punjabis and 47.9 % (N = 57 out of 119) in 
Urdu speaking (Table 3). 
Binary logistic regression analysis 
 
Logistic regression was performed to ascertain 
the effects of age, gender, Insulin use, and 
duration of DM, BMI, HbA1c, FBS, RBS and 
serum cholesterol levels on the likelihood that the 
participants have DR. Presence of DR was the 
dichotomous dependent variable and others 
were independent co-variables. 
 
The logistic regression model was statistically 
non-significant (χ2 = 15.95; p > 0.05). The model 
explained 14.3 % (Nagelkerke R2) of variance in 
DR and was correctly classified 66.7 % of cases. 
Increasing BMI was associated with decreased 
likelihood of DR (Exp (B) = 0.921, p < 0.05) 
whereas increased cholesterol levels were 
associated with rise in the occurrence of DR (Exp 
(B) = 1.008, p < 0.05). 
 
Gender-based binary logistic regression analysis 
The logistic regression analysis was performed 
after stratification on gender basis with DR as 
dichotomous dependent variable and Age, 
duration and all blood and lipid profiles as 
covariates. The logistic regression model was 
statistically non-significant for males (χ2 = 9.25; p 
> 0.05) and significant for females (χ2 = 29.14; p 
< 0.05). The model explained 27 % (Males) and 
34% (Females) variance in DR (Nagelkarke R2). 
The experimental models were correctly 
classified 78 and 71.7 % for males and females 
respectively. The effects of covariate were not 
found to affect the variable significantly. 
 
Adherence to prescribed medication 
 
A four item Moriskey’s scale was included in the 
questionnaire. Questions asked were about 
forgetfulness to take medicine, careless attitude 
to take medicine and when do patients drop their 
medication? When felt better or worse? On 
affirmative response 0 points were given and on 
negative responses 1 point, allotted numbers 
were totaled out of 4. 0 points were considered 
“High adherence”, 1 – 2 points were considered 
“Medium adherence” whereas 3 – 4 points were 
considered “Low adherence”. 
 
48 % (n = 74) of the study population was found 
with high adherence (0 points), 36 % (n = 56) 
were found with medium adherence (1 – 2 
points) whereas 16 % (n = 24) patients were 
found with low adherence (3 – 4 points); χ2 = 
24.99, p < 0.001.  There was no gender 
difference found in the responses of medication 
adherence (χ2 = 0.77, NS).  
 
Table 2: Main clinical characteristics in subjects stratified according to gender 
 
Variable Male Female χ2/t  
(p*) N = 42 N = 112 
Age (Years) 56 ± 9 49 ± 10 4.54 (p < 0.001*) 
Height (cm) 165.8 ± 6.5 153 ± 6 10.83 (p < 0.001*) 
Weight (kg) 67 ± 13 63 ± 14 1.54 (p > 0.05) 
BMI (Kg/m2) 24 ± 5 27 ± 5 2.88 (p < 0.025*) 
Duration of DM II (Years) 12 ± 7 11 ± 6 0.977 (p > 0.05) 
Weight  Normal 28 44 9.2 (0.025*) 
Over 14 68 
Marital 
Status 
Married 38 73 10.74 (p < 0.05*) 
 Single 1 2 
Widowed 3 37 
Systolic (SBP) mmHg 128 ± 15 126 ± 20 0.58 (p > 0.05) 
Diastolic (DBP) mmHg 85 ± 12 84 ± 11 0.78 ( p > 0.05) 
Fasting glucose (mg/dl) 179 ± 87 194 ± 92 0.94 (p > 0.05) 
Random glucose (mg/dl) 270 ± 108 280 ± 104 0.46 (p > 0.05) 
GlycatedHb (%) 7.7 ± 1.27 7.67 ± 1.3 0.126 (p > 0.05) 
Cholesterol (mg/dl) 184 ± 50 187 ± 47 1.3 (p > 0.05) 
Triglycerides (mg/dl) 159 ± 77 178 ± 87 1.3 (p > 0.05) 
Low density lipoprotein (LDL) mg/dl 108 ± 33 110 ± 29 0.27 (p > 0.05) 
High density lipoprotein (HDL) mg/dl 46 ± 9 46 ± 9  0.14 (p > 0.05) 
Very low density lipoprotein (VLDL) mg/dl 31 ± 14 36 ± 17 1.82 (p > 0.05) 
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Table 3: Prevalence of retinopathy and adherence to prescribed medication in the sample population 
 
Variable Male Female χ2/t  
(p*) N = 42 N = 112 
Visual disturbances    
Regular 15 74 15.27 (p < 0.005*) 
Frequent 8 11 
Occasional 7 17 
Never 12 10 
Cataract    
Yes (Both eyes) 11 42 1.75 (p > 0.05) 
Yes  (One eye) 2 5 
No 29 65 
Retinal problem    
Yes (Both eyes) 0 5 2.42 (P > 0.05) 
 
 
Yes  (One eye) 1 1 
No 41 106 
Glaucoma    
Yes  (One eye) 1 5 3.54 (P > 0.05) 
No 41 107 
Cataract surgery    
Yes (Both eyes) 3 10 0.34 (P > 0.05) 
Yes  (One eye) 4 8 
No 35 94 
Laser treatment     
Yes (Both eyes) 2 7 0.23 (p > 0.05) 
Yes  (One eye) 6 13 
No 36 92 
Diabetic retinopathy   
Yes 24 51 0.66 (p > 0.05) 
No 17 49 
Retinopathy status    
Mild NPDR  9 29 0.97 (p > 0.05) 
Moderate – severe NPDR 2 3 
PDR 1 4 
CSMO + Maculopathy 6 13 
No DR 24 63 
Adherence to prescribed medication 
High Adherence 20 54 0.77 ( p > 0.05) 
Medium Adherence 17 39 




Diabetes mellitus is becoming a major health 
issue by presenting two major problems namely 
increase in the number of diabetics and increase 
in the prevalence of disastrous long term 
complications resulting in amputations, 
cardiovascular disorders, end stage renal [15-20] 
disease and blindness [1]. DR is the leading 
cause of blindness in long-standing patients of 
diabetes mellitus [9] and is responsible for ~ 
10,000 new blind cases each year in USA alone 
[17] between the ages of 20 to 75 years [21]. 
 
Previous studies showed that 40.64 % DR 
subjects were found in Egypt [22], 42 % in Oman 
[11], 25.9 % in Nepal [23], 3.7 % in South Korea 
[24], 27 % in Srilanka [14], 17.6 % in India [25] 
and 37% in Iran [26]. Decreased prevalence in 
South Korea is most probably because the target 
population was elderly patients. Different studies 
from Pakistan also showed extremely variable 
data regarding DR i.e. 28.67 % prevalence in 
Rawalpindi [27], 25.5 – 40.93 % in Hyderabad 
[11], 23 % in Bahawalpur [28] and 15 to 43 % in 
different studies in Karachi [29-31]. Our results 
are in accordance with the studies above where 
we found 43 % prevalence of diabetic retinopathy 
in different levels of severity in patients who had 
DM II for more than 5 years. There was very 
surprising fact that 85.71 % patients reported 
visual disturbances with blurring of vision and 
decreased visual acuity but only 4.5 % patients 
were aware that they are suffering from DR. This 
is probably becomes none of the patients 
undergo a regular screening for DR six monthly. 
 
Diabetes mellitus is a leading cause of cataract 
although classical cataract is not common but 
age related cataract occur earlier in DM [32]. In 
our study 34 a third of the patients reported 
bilateral cataract while 4.55 % patients reported 
unilateral cataract, however, since the patients 
were mostly illiterate they were unable to say 
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whether they developed cataract before diabetes 
or after. Thus we were unable to correlate the 
occurrence of cataract with DM II. The incidence 
of glaucoma was non-significant and association 
of glaucoma with diabetes in present study could 
not be established because patients were not 
confidently aware of whether presence of 
glaucoma was before or after diabetes inset.  
 
According to Zoungas [20] there is 38 % rise in 
the risk of microvascular abnormalities by 1 % 
rise in HbA1c levels [33]. Threshold of HbA1c for 
macro-vascular problems and death is ~ 7 % 
whereas for micro-vascular abnormalities is ~ 6.5 
% [20]. According to another study HbA1c levels 
do not have a direct association with DR rather 
these variables are strongly correlated with 
nephropathy [18]. It is postulated that 
progression to advanced eye disease is 
significantly associated with raised HbA1c levels 
[18]. In our study, mean HbA1c level in the study 
population was found to be 7.86. No patient with 
advanced eye disease was found, however, 
there were five patients with proliferative diabetic 
retinopathy. 
 
When we studied the mean HbA1c levels of 
different groups, we found non-significant 
difference between groups as the levels were 7.9 
± 1.5, 7.74 ± 2.06 and 7.52 ± 1.08 % for non-
proliferative DR, proliferative DR and normal 
groups respectively. We performed regression 
analysis to know any relationship between 
presence of DR and HbA1c, but according to our 
data the result was found non-significant (HbA1c 
= 7.86 ± 1.3 %, Exp (B) = 1.27, p > 0.05). 
According to Fowler, glycemic target for HbA1c is 
6.5 % and in present study average HbA1c was 
found to be 7.68 %. Despite this difference in the 
HbA1c levels we could not establish any 
relationship between DR and HbA1c, as it is 
considered to strongly correlate with diabetic 
nephropathy nor diabetic retinopathy [16]. The 
findings of the present study again is in 
agreement with this as logistic regression 
between HbA1c and nephropathy showed highly 
significant correlation [Exp(B) = 1.61, p < 0.001, 
43 % Nagelkarke R2 value with 72 % corrected 
classification], thereby proving a direct 
correlation of HbA1c levels with nephropathy 
rather than retinopathy. 
 
Gender based analysis of this study showed that 
men with normal weight were prone to develop 
DR (66 %, χ2 = 4.667, p < 0.05) as compared to 
overweight men, whereas overweight females 
were more prone to develop DR (60.7 %, χ2 = 
5.143, p < 0.05) when compared with normal 
weight females. According to Verma [34] and 
Group [35] their studies did not showed gender 
difference in prevalence of DR. Our results were 
also found in accordance with these studies 
where we were unable to find any gender 
preponderance (p > 0.05) for presentation of DR. 
When Moriskey’s scale of Adherence to 
prescribed medication was applied to the study 
population, 48 % (N = 74) people showed high 
adherence to medication and only 16 % (N = 24) 
of the patients showed low adherence. Pearson’s 
Chi square test of correlation was also run 
between adherence to medication and 
presentation of DR, here we found non-
significant correlation between two variables (χ2 
= 0.44, NS). This may be due to the fact that 
equal numbers of frequencies were found in 
retinopathy group and normal group in all the 
three stages of adherence i.e. high, medium and 
low adherence. 
 
There was another fact put forth by the patients 
during the interview that majority of the patients 
adhere to medication only when it is provided 
from the charity fund of hospital. They were 
unable to buy the medicines from the retail 
pharmacy. Therefore despite the fact that 
adherence to medication is high in the study 
population but even then relative risk to develop 
DR in female was found to be 52 % (p < 0.05) 
when patients were on insulin therapy most 
probably due to discontinuation of the medicine 
on unavailability of charity medication in 
pharmacy. 
 
This dependence on charity medication shows 
in-efficient glycemic control that may contribute 
to occurrence and progression of diabetic 
retinopathy. In the OPD, every patient with the 
slightest initiation of complication is 
recommended with insulin. In advanced eye 
disease and Proliferative diabetic retinopathy 
anti-VEGF injections and/or laser photo-
coagulation were prescribed. The Sind 
Government hospital does not have the facility of 
laser photo-coagulation; therefore patients 
needing coagulation therapy are referred to other 
hospitals with the facility further increasing the 
difficulties of the patients. 
 
Efficient management to achieve euglycemic 
state is necessary, failing to do so show such a 
high prevalence (43 %) of DR in such a small 
sample of very small part of Karachi metropolis. 
 
Major contributing factor from the above 
discussion, in development of DM in the study 
population are mental stress and socio-economic 
constraints. These factors are further contributing 
in development and progression of complications 
as patients are unable to avail basic health care 
facilities due to poverty and illiteracy. Patients do 
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not have the concept of regular medical care and 
checkups. Hospital has its own limitations and 
burdens due to which medication in the charity 
fund is not provided regularly.  
 
It is clear from the foregoing that if medication is 
provided regularly, patients show adherence to 
the prescribed medication; otherwise they do not 
buy medicines, leading uncontrolled blood sugar 




Prevalence of DR in the participants of the 
present study is 42.86 % which is fairly high 
among the population of New Karachi Township. 
Necessary measures should be taken to control 
and prevent the progress of complication for 
which effective glycemic control is a key factor. 
Complete screening at the time of first visit is 
strongly recommended. 
 
For Pakistani population, especially females, with 
a low literacy rate, effective measures should be 
taken to embark on public awareness through 
the media, yearly free screening for eye disease 
complications, adequate availability of 
medications in government hospitals and 
continued provision of affordable medicines and 
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